Finance

Beta
Senarai
Sektor ekuiti
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Buka
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
OZTA:FRA
Grifols SA Class A
€8.68
-0.75%
(-0.066) 1H
30 Apr, 10:00:00 PTG GMT+2  ·   EUR
Semua simbol
SimbolPriceChange% Change
Generating top insights for OZTA...
Buka
€8.68
High
€8.68
Low
€8.68
Mkt. cap
5.52B
Avg. vol.
268.00
Volume
0.00
Dividend
1.73%
Quarterly dividend
€0.04
Ex dividend date
11 Ogo 2025
P/E ratio
14.70
52-wk high
€13.42
52-wk low
€8.05
EPS
€0.59
No. of employees
25K
News stories
From sources across the web
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A
CEONacho Abia
Employees25.3K
Founded18 Nov 1940
Headquarters-
Sector-
Websitegrifols.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mac 2025
Jun 2025
Sep 2025
Dis 2025
Revenue
1.79B
1.89B
1.87B
1.98B
Cost of goods sold
1.08B
1.15B
1.11B
1.28B
Cost of revenue
1.08B
1.15B
1.11B
1.28B
Research and development expenses
96.05J
96.19J
97.01J
90.82J
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
315.37J
298.06J
273.76J
262.86J
Operating expense
411.42J
394.25J
370.34J
353.11J
Total operating expenses
1.49B
1.54B
1.48B
1.63B
Operating income
293.22J
349.54J
381.18J
347.38J
Other non operating income
-
8.08J
-
-33.00J
EBT including unusual items
115.26J
190.51J
198.13J
111.10J
EBT excluding unusual items
134.52J
190.51J
227.20J
183.10J
Income tax expense
22.84J
52.13J
54.71J
-14.68J
Effective tax rate
19.82%
27.36%
27.61%
-13.21%
Other operating expenses
-
-
-430.00K
-570.00K
Net income
59.72J
117.06J
126.96J
98.25J
Net profit margin
3.34%
6.19%
6.81%
4.96%
Earnings per share
-
0.19
-
-
Interest and investment income
-
9.56J
-
36.00J
Interest expense
-153.59J
-141.43J
-156.07J
-107.99J
Net interest expenses
-153.59J
-131.88J
-156.07J
-71.99J
Depreciation and amortization charges
-
-
-
-
EBITDA
404.97J
414.24J
484.03J
422.88J
Gain or loss from assets sale
-
732.00K
-
2.00J
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

Tugasan saya
Anda belum membuat tugasan lagi
Tugasan anda akan dipaparkan di sini. Jadualkan tugasan dan manfaatkan Google Finance semasa anda tiada.
Templat
Ringkasan senarai amatan
Analisis prapasaran harian bagi senarai amatan anda
Pendapatan Akan Datang
Laporan pendapatan akan datang dalam minggu ini
Kemudahubahan & Jumlah yang Tidak Normal
Amaran awal kemudahubahan dan jumlah hari ini
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer